References
- Pickles T, Morris WJ, Kattan MW, Yu C, Keyes M. Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer. Brachytherapy 2011;10:9–14.
- Norderhaug I, Dahl O, Hoisaeter PA, Heikkila R, Klepp O, Olsen DR, Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness. Eur Urol 2003;44:40–6.
- Giberti C, Chiono L, Gallo F, Schenone M, Gastaldi E. Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. World J Urol 2009;27:607–12.
- Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Erectile function durability following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2009;75:639–48.
- Aaltomaa SH, Kataja VV, Lahtinen T, Palmgren JE, Forsell T. Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy – morbidity and outcome results. Radiother Oncol 2009;91:213–16.
- Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, 10-Year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients. Int J Radiat Oncol Biol Phys 2010; July 31. [Epub ahead of print].
- Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 2006;66:669–73.
- Moon K, Stukenborg GJ, Keim J, Theodorescu D. Cancer incidence after localized therapy for prostate cancer. Cancer 2006;107:991–8.
- Brenner DJ, Hall EJ, Curtis RE, Ron E. Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum. Gastroenterology 2005;129:773–4; author reply 774–5.
- Nabi G, Ansari MS, Singh I, Sharma MC, Dogra PN. Primary squamous cell carcinoma of the prostate: a rare clinicopathological entity. Report of 2 cases and review of literature. Urol Int 2001;66:216–9.